Overview of Oncology’s services provided to Eastern North Carolina
Oncology has a legacy of excellence in care and specialized expertise. It is a regional resource for eastern North Carolina, and has assisted in the development of cancer programs in several outlying hospitals. Because of the complexity of these diseases and the rapid development of new therapies, multidisciplinary disease oriented care is our model. We offer specialized programs in breast cancer, aero digestive tract malignancy, melanoma, urologic malignancies, hematologic malignancies, benign hematology and hemostasis.
On the inpatient service, a team approach is used which consists of staff physicians, a cancer nutritionist, cancer pharmacist, cancer program chaplain and specially trained nurses. The service offers not only the most current chemotherapy and biotherapy, but a comprehensive array of patient and family oriented services including symptom management, pain control, family education, discharge planning, home care and (when needed) hospice care planning.
Our outpatient services are coordinated at the Leo Jenkins Cancer Center. This facility is adjacent to the Brody School of Medicine and the Vidant Medical Center. Nursing services are provided by oncology accredited nurses, and patients in the naturally lighted chemotherapy bay are assisted by case managers, pharmacists and social workers. The Department is a major participant in clinical trials and we committed to the delivery of cutting edge care to the residents of eastern North Carolina.
Our ACGME accredited fellowship training program endeavors to provide our trainees with the best tools to care for patients with hematologic or oncologic disease. We provide medical therapies (chemotherapy, nutrition) as well as radiation therapy (including the Gamma Knife) and cancer surgery (surgical oncology).
The Jenkins Center offers expert care in breast cancer, cancers of the lung and esophagus, digestive and liver cancers, and endocrine cancers, such as thyroid cancer. Our physicians are aggressively committed to participating in clinical trials, and seek those trials that address the specific needs of our patients. We support both basic science research, as well as clinical research into the causes and treatment of cancer.